Intervention
Lumbar puncture
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 15 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
15 shownInvestigation of AlzHeimer's Predictors in Subjective Memory Complainers - Extension StudyNCT05806697 · 2023-04-14
RECRUITINGTanycytes in Alzheimer's Disease and Frontotemporal DementiaNCT05288842 · 2022-09-06
RECRUITINGSerotonin Release in Premotor and Motor PDNCT05516732 · 2022-07-01
RECRUITINGLongitudinal Investigation of I2BS in PDNCT05516719 · 2021-11-01
RECRUITINGICP & Outflow StudyNCT06436820 · 2024-06-01
UNKNOWNCurrent Treatment Methods of Idiopathic Intracranial HypertensionNCT06353412 · 2024-06-01
UNKNOWNMonitoring for Cancer Spread to the Central Nervous System (CNS) in People With Breast CancerNCT05130840 · 2022-07-13
ACTIVE_NOT_RECRUITINGEpilepsy in Alzheimer's Disease: Effect on Disease ProgressionNCT04131491 · 2020-02-12
UNKNOWNDECISIve - DiagnosE Using the Central veIn SIgn v1.0NCT05533905 · 2019-12-09
COMPLETEDEctosomes, New Biomarkers of Tau Pathology?NCT03381482 · 2017-12-20
COMPLETEDEvaluating Raised Intracranial Pressure Using MR ElastographyNCT03096743 · 2017-01-10
ACTIVE_NOT_RECRUITINGOptic Nerve Sheath Diameters in Idiopathic Intracranial Hypertension PatientsNCT04603118 · 2014-05-01
COMPLETEDAfrican American Alzheimer's Progression Markers - CSF and Neuro-ImagingNCT02089555 · 2013-09-01
COMPLETEDEfficacy of Cholecalciferol (Vitamin D3) for Delaying the Diagnosis of MS After a Clinically Isolated SyndromeNCT01817166 · 2013-07-16
COMPLETEDIdentification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive ImpairmentNCT01425957 · 2011-12-01
COMPLETEDCommon conditions
Alzheimer Disease4Mild Cognitive Impairment3Idiopathic Intracranial Hypertension2Multiple Sclerosis2Neurodegeneration2Neurodegenerative Diseases2Parkinson Disease2Parkinson's2Parkinson's Disease2Positron Emission Tomography2Alzheimer's Disease1Breast Cancer1Eye Change1Frontotemporal Dementia1IIH - Idiopathic Intracranial Hypertension1Memory Complaint1Memory Disorders1Pseudotumor Cerebri1
Leading sponsors
University Hospital, Lille
2
University of Exeter
2
Assiut University
1
Centre Hospitalier Universitaire de Nīmes
1
Ege University
1
Emory University
1
Guy's and St Thomas' NHS Foundation Trust
1
Institut National de la Santé Et de la Recherche Médicale, France
1
Mayo Clinic
1
Memorial Sloan Kettering Cancer Center
1
Nottingham University Hospitals NHS Trust
1
Qualissima
1
Universitair Ziekenhuis Brussel
1
Trial status mix
COMPLETED6
RECRUITING4
UNKNOWN3
ACTIVE_NOT_RECRUITING2
Phase mix
NA6
PHASE31
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.